pSivida Corp. Share Price Nasdaq

Stocks

09/16/09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/16/14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/16/02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/15/28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/15/14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	+1.23%	-3.08%	+53.96%	+87.98%	5.53TCr
ARGENX SE	+5.09%	+6.18%	+63.69%	+62.06%	5.42TCr
INSMED INCORPORATED	+0.72%	-2.19%	+4.36%	+409.54%	2.31TCr
BIONTECH SE	+0.25%	+0.08%	-17.39%	-15.22%	2.32TCr
WUXI BIOLOGICS (CAYMAN) INC.	+1.03%	-0.76%	+40.14%	-3.59%	2.03TCr
GENMAB A/S	-0.37%	+0.42%	+37.47%	-31.61%	1.79TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.87%	-2.80%	+37.96%	+600.00%	1.58TCr
PHARMAESSENTIA CORPORATION	-2.54%	-12.88%	+168.62%	+289.45%	1.5TCr
EXELIXIS, INC.	+1.22%	+0.18%	+25.14%	+182.63%	1.38TCr
Average	+0.66%	-0.37%	+46.00%	+175.69%	2.65TCr
Weighted average by Cap.	+1.56%	+1.19%	+46.49%	+138.40%